Knopp posts data of KB-3061 working on KCNQ2 Epileptic Encephalopathy

Knopp posts data of KB-3061 working on KCNQ2 Epileptic Encephalopathy

Published: 10 minutes ago By Mateen Dalal

KCNQ2 epileptic encephalopathies is a serious type of neonatal epileptic condition which manifests in newborn children during the first week if their lives. This disease is being addressed by various pharmaceutical compa....

Novo Nordisk and Medtronic team up to offer digital diabetes solutions

With growing population of diabetic patients, diabetes management is becoming a daunting activity. Sugar level management and insulin injections tracking is a difficult work. Thus, leading pharmaceutical companies are collaborating with med....

Akesis unveils its advanced Galaxy™ RTi and Gemini360 at ASTRO 2019

The healthcare company will showcase its drugs in the ASTRO annual meeting 2019 that could help offer improved efficiency and confidence in treatment delivery. Akesis, Inc., a hospital and healthcare company based in the U.S. that offers ....

Adverum reveals positive results from Phase 1 trial of ADVM-022

The drug was well tolerated and was safe, and has shown the capacity to improve the treatment paradigm for patients with wet AMD. Adverum Biotechnologies, Inc., a company that develops medical therapies for ocular and rare diseases, recent....

Apple initiates new medical studies focusing on various health issues

The company plans to join various institutions in order to accomplish its new medical studies which focus on hearing, women’s health and mobility. Apple Inc., a multinational tech company, has recently announced that it is planning t....

Rocket Pharma unveils Phase 1/2 trial data for its Fanconi Anemia drug

The manuscript includes data of the first four trial participants that were treated with RP-L102 under the Phase 1/2 FANCOLEN-I study.   First RP-L102 trail data demonstrates increase in bone marrow engraftment levels, which furthe....

Ford to launch eight new electric vehicles across Europe this year

Electric variants of the company’s Puma and Kuga SUVs as well as the Mondeo sedan will be the new launches in Europe.   The company also plans to unveil nine more electric vehicles across Europe by 2024. Ford Motor Co, Amer....